南昌双向情感障碍医院找那家(南昌哪家医院能治精神障症) (今日更新中)

CANBERRA, Oct. 15 (Xinhua) -- Prisoners and health experts on Saturday told national broadcasting network ABC News that they are concerned of a looming HIV epidemic in Australia's prisons.The warning came following a test report undertaken in August showed that 40 percent of inmates at a correctional center in Canberra of Australia tested positive to Hepatitis C.According to the head of the Alcohol and Drug Service based at St Vincent's Hospital in Sydney, Alex Wodak, roughly 25 percent of Australia's prison population are injecting drugs, and he is concerned about the risk of an HIV explosion in Australia originating in prisons."Were Australia to have an epidemic of HIV beginning among people who inject drugs, it is almost certain that it would begin in one of our prisons. So we are very exposed to this risk," he told ABC News on Saturday.The Australia Capital Territory state government has proposed a trial prison needle exchange program in Canberra's correctional center, and Paul Cubitt, who currently works at the Alexander Maconochie Center in Canberra, said he has never seen so many syringes in a jail."Under a controlled regime it will actually take those needles that currently exist within a correctional center out of the environment, and prisoners will be more willing to use a clean item under a level of anonymity which then protects them and protects staff," he said.Meanwhile, The Community and Public Sector Union 's national secretary, Nadine Flood, agrees action must be taken to curb prisoner drug use.Dr Wodak noted that prison needle exchange programs have been operating overseas for over a decade with ten countries provide inmates with clean needles, and said it is shameful Australian prisons are lagging behind.

WASHINGTON, Nov. 18 (Xinhua) -- The U.S. Food and Drug Administration (FDA) on Friday approved Erwinaze to treat patients with acute lymphoblastic leukemia (ALL), who have developed an allergy to E. coli derived asparaginase and pegapargase chemotherapy drugs used to treat ALL.Acute lymphoblastic leukemia is a type of cancer in which the bone marrow makes too many lymphocytes, a type of white blood cell. White blood cells help the body fight infection and are formed in the bone marrow.Erwinaze is injected directly into the muscle three times a week and works by breaking down one of the body's protein building blocks (the amino acid, asparagine) that is present in the blood, and is necessary for the growth of all cells. Leukemia cells cannot produce this protein building block. When a patient is treated with Erwinaze the leukemia cells die. Normal human cells are able to make enough asparagine for their own needs through biosynthesis and will not be affected by treatment with Erwinaze."The approval of Erwinaze underscores the FDA's commitment to the approval of drugs for conditions with limited patient populations with unmet medical needs using novel trial endpoints," said Richard Pazdur, director of the Office of Hematology and Oncology Products in the FDA's Center for Drug Evaluation and Research.Side effects associated with Erwinaze treatment include serious allergic reactions, inflammation of the pancreas, high blood levels of liver enzymes, blood clotting, bleeding, nausea, vomiting and high blood sugar.

RIO DE JANEIRO, Oct. 11 (Xinhua) -- The World Health Organization (WHO) on Tuesday highlighted Brazil's efforts to stop tuberculosis (TB) in its territory.According to a report released by the organization, Brazil achieved significant and sustained improvement in the fight against TB in the past years.Along with Cambodia, China, Uganda, and Tanzania, Brazil is one of the five nations which succeeded in reducing TB death rate in 2010 by half compared with 1990.The number of TB cases in the world fell for the first time in 2010, said the WHO. But with 8.8 million cases, the disease remained a major global health problem, said the organization.Although the TB death rate had significantly dropped over the years, the disease killed 1.4 million people around the world in 2010 alone.

ULAN BATOR, Dec. 1 (Xinhua) -- Mongolia will continue to curb the spread of HIV and strive to maintain a low prevalence of the AIDS epidemic, a government official said Thursday.Gansukh Battulga, an official with the National Committee on AIDS, told Xinhua that Mongolia is currently an HIV low-prevalence country with a total of 99 people, 15 of whom have died, infected with the virus that causes AIDS."Among the 99 HIV infected cases, 81 percent are men, and the remaining 19 percent are women," Battulga said. "Among the male infected cases, 83 percent belong to MSM (men who have sex with men) group while sex workers account for 54 percent of the female infected cases."The official said the government has launched a variety of programs and tasked the National Committee on AIDS to coordinate all organizations in fighting the epidemic.According to a National Strategy Plan for 2010-2015, Mongolia will strive to maintain its current low HIV-prevalence rate of below 5 percent in the most-at-risk population.

BEIJING, Jan. 4 (Xinhua) -- The Chinese currency Renminbi, or the yuan, rose 8 basis points to a record high of 6.3001 against the U.S. dollar on Wednesday, according to the China Foreign Exchange Trading System.In China's foreign exchange spot market, the yuan is allowed to rise or fall by 0.5 percent from the central parity rate each trading day.The central parity rate of the yuan against the U.S. dollar is based on a weighted average of prices before the opening of the market each business day.

来源：资阳报